Tead4 (216-434);y429f complexed with yap peptide (60-100) and myristoate (covalently bound) at 2.05a (p41212 crystal form); myristoylation was done by adding myr-coa Deposition Author(s): Kallen, J.
Date: 2018-04-25 Method: X-RAY DIFFRACTION Resolution: 2.05 Å Organism(s): Homo Sapiens Sequences Data: 6GE5_A , 6GE5_L
X-ray structure of tead4(e263a+y429f mutant) complexed with yap(wildtype): the role of residual flexibility and water molecules in the adaptation of a bound intrinsically disordered protein to mutations at a binding interface Deposition Author(s): Kallen, J.
Date: 2018-04-25 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 6GE6_A , 6GE6_L
Tead4 (216-434) complexed with yap peptide (60-100);s94a and myristoate (covalently bound) at 1.70a (p41212 crystal form); myristoylation was done by adding myr-coa Deposition Author(s): Kallen, J.
Date: 2018-04-26 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 6GEC_A , 6GEC_L
Tead4 (216-434);e263a complexed with yap peptide (60-100); s94a and myristoate (covalently bound) at 1.96a (p41212 crystal form); myristoylation was done by adding myr-coa Deposition Author(s): Kallen, J.
Date: 2018-04-26 Method: X-RAY DIFFRACTION Resolution: 1.96 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 6GEE_A , 6GEE_L
Tead4 (216-434);y429f complexed with yap peptide (60-100); s94a and myristoate (covalently bound) at 2.23a (p41212 crystal form); myristoylation was done by adding myr-coa Deposition Author(s): Kallen, J.
Date: 2018-04-26 Method: X-RAY DIFFRACTION Resolution: 2.23 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 6GEG_A , 6GEG_L
Tead4 (216-434);e263a+y429f complexed with yap peptide (60- 100);s94a and myristoate (covalently bound to lys344, not cys367!) at 1.65a (p41212 crystal form); myristoylation was done by adding myr-coa Deposition Author(s): Kallen, J.
Date: 2018-04-26 Method: X-RAY DIFFRACTION Resolution: 1.65 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 6GEI_A , 6GEI_L
Tead4 (216-434);y429f complexed with yap peptide (60-100) and myristoate (covalently bound) at 2.28a (p212121 crystal form); myristoylation was done by adding myr-coa Deposition Author(s): Kallen, J.
Date: 2018-04-26 Method: X-RAY DIFFRACTION Resolution: 2.28 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 6GEK_A , 6GEK_B , 6GEK_L , 6GEK_M
In vitro and in vivo characterization of a novel, highly potent p53-mdm2 inhibitor Deposition Author(s): Kallen, J.
Date: 2018-05-03 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Homo Sapiens Sequences Data: 6GGN_A
X-ray structure of tead4(y429h) mutant) complexed with yap (wildtype): molecular and structural characterization of a tead mutation at the origin of sveinsson's chorioretinal atrophy Deposition Author(s): Kallen, J.
Date: 2018-08-30 Method: X-RAY DIFFRACTION Resolution: 1.65 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 6HIK_A , 6HIK_L
X-ray structure of tead1(y421h mutant) complexed with yap(wildtype): molecular and structural characterization of a tead mutation at the origin of sveinsson's chorioretinal atrophy Deposition Author(s): Kallen, J.
Date: 2018-08-30 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Homo Sapiens Sequences Data: 6HIL_A , 6HIL_D , 6HIL_B , 6HIL_C , 6HIL_L , 6HIL_O , 6HIL_M , 6HIL_N